BofA analyst George Staphos upgraded Pactiv Evergreen to Buy from Neutral with a price target of $16, up from $14. The firm cites valuation for the upgrade. Pactiv should benefit from its Pactiv Evergreen Production System, a continuous improvement program that has added margin in recent quarters, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PTVE:
